We are thrilled to announce that ProvaLabs, a deep-tech startup specializing in bio-sensing technology, has successfully closed a Pre-Series A funding round. This round saw significant participation from Capstone Partners, Seoul National University Technology Holdings, and Life Asset Management.
This investment will accelerate the commercialization of our non-destructive organoid monitoring technology. Our key priorities include scaling our sensor production, strengthening our R&D team with world-class expertise, and advancing pre-clinical evaluation projects.